Continues to Work Diligently Towards Regaining Compliance CHICAGO / Feb 28, 2024 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the common stock of the Company from... Read More

CHICAGO / Feb 28, 2024 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief Executive Officer, and Lee Westerfield, interim Chief Financial Officer, will present at the TD Cowen Annual Health Care Conference on Monday, March 4, 2024, at 9:50 AM Eastern Time. About Veradigm® Veradigm is a healthcare... Read More

Veradigm to Leverage ScienceIO’s Leading Healthcare Artificial Intelligence (AI) Platform on the Company’s Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare Expected to Provide Highly Differentiated and More Advanced Products to Veradigm Customers Acquisition Will Help Accelerate Platform Improvements Across the Veradigm Network, including the Provider, Payer and Life Sciences... Read More

Expects Not to File Required Financial Statements by Nasdaq’s February 27, 2024 Deadline Working Diligently to File Required Financial Statements and Restore Listing Adopts Limited Duration Stockholder Rights Plan CHICAGO / Feb 27, 2024 / Business Wire / Veradigm Inc. (NASDAQ: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, announced today that the Company does not expect... Read More

Recently debuted Veradigm Payer Insights is delivering care cap alerts to thousands of providers and growing fast as demand for payer-provider interoperability continues to increase CHICAGO / Feb 22, 2024 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will be highlighting the new Veradigm Payer Insights solution at the ViVE 2024... Read More

Using de-identified data for 53 million unique cardiovascular patients, the report examines prevalence across all 50 states and a variety of demographics CHICAGO / Feb 20, 2024 / Business Wire / Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart failure? The South, according to this analysis on cardiovascular disease (CVD) from Veradigm Inc. (NASDAQ: MDRX), a leading provider of... Read More

CHICAGO / Feb 13, 2024 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving cardiovascular health through increased influenza vaccination education. Influenza vaccination is associated with a lower risk for adverse cardiovascular events, with an... Read More

CHICAGO / Jan 10, 2024 / Business Wire / The new leadership team at Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, has provided refreshed estimated, unaudited ranges of financial information for fiscal 2023. Dr. Shih-Yin Ho, Interim CEO, and Lee Westerfield, Interim CFO, will discuss Veradigm’s mission, business and operations, and innovation strategy, as well as its estimated... Read More

Providers using Veradigm EHRs to gain access to longitudinal patient records, improving interoperability and driving better treatment decisions FISHKILL, N.Y. and CHICAGO, Ill. , Jan. 9, 2024 /PRNewswire/ -- MedAllies, a leading healthcare interoperability and connectivity services provider, announced today that Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology services, has selected... Read More

CHICAGO / Jan 04, 2024 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Dr. Shih-Yin Ho, Veradigm interim Chief Executive Officer and board member, and Lee Westerfield, interim Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 11:15 AM PST. Dr. Shih-Yin Ho and Lee... Read More

CHICAGO / Jan 02, 2024 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the acquisition of Koha Health, a full-service revenue cycle management (RCM) company. With this acquisition, Veradigm further adds to its depth of offerings and expertise as a leading provider of revenue cycle services in the ambulatory healthcare market. “Today’s announcement... Read More

CHICAGO / Dec 13, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX (the “Company”)) announced today that it received a decision from the Nasdaq Hearings Panel (the “Panel”) granting its request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rules”) on or before February 27, 2024, and certain other conditions, including... Read More

CHICAGO / Dec 11, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will now offer a conversational artificial intelligence (AI) agent for Practice Fusion Billing Services, a Veradigm Network solution. Created to quickly answer questions in a conversational format designed to meet client needs, this enhancement will help simplify the... Read More

Greg Garrison Named Executive Chairman; Dr. Shih-Yin Ho Appointed Interim CEO; Lee Westerfield Appointed Interim CFO CHICAGO / Dec 08, 2023 / Business Wire / Veradigm Inc. (Nasdaq: MDRX) announced today that the Company’s Board of Directors appointed current Chairman, Greg Garrison, as Executive Chairman, and current director, Dr. Shih-Yin (“Yin”) Ho, as interim Chief Executive Officer. In addition, Lee Westerfield, who... Read More

CHICAGO / Nov 17, 2023 / Business Wire / Veradigm Inc. (Nasdaq: MDRX) announced today that, as expected, it received a notice from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”), Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Q1 Form... Read More

New solution to help providers digitally engage with patients, improving both practice efficiency and the patient experience CHICAGO / Nov 07, 2023 / Business Wire / Veradigm, Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today that it will now offer a new solution to help increase payment rates, accelerate time to payment, and reduce manual reconciliation time for healthcare... Read More

CHICAGO / Oct 09, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX) announced today that, on October 6, 2023, it received a notice from Nasdaq indicating that the temporary stay of delisting of the Company’s common stock has been extended pending a hearing before the Nasdaq Hearings Panel (the “Panel”) on November 16, 2023, and the issuance of a final Panel decision. Previously, the Company disclosed that, on September 20,... Read More

New chapter in pharmacy connectivity, expansion of the Veradigm Network and FDB Vela ePrescribing Network introduced SOUTH SAN FRANCISCO and CHICAGO , Oct. 6, 2023 /PRNewswire/ -- FDB (First Databank, Inc.) , a major provider of drug knowledge that helps healthcare professionals make precise decisions, and Veradigm (NASDAQ: MDRX), a well-known and respected provider of healthcare data and technology solutions, announced... Read More

Expanded database will enable deeper analysis and insights to enhance care delivery and improve behavioral health outcomes CHICAGO & NEW YORK / Oct 02, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, and Holmusk , a leading global behavioral health real-world evidence company, today jointly announced the next stage in its strategic collaboration. The... Read More

CHICAGO & BOSTON / Sep 28, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions and On Belay Health Solutions, the company on a mission to empower primary care practices to succeed in value-based care, announced today a strategic collaboration to support primary care providers in improving patients’ health outcomes while strengthening their practices’ financial... Read More

CHICAGO / Sep 22, 2023 / Business Wire / Veradigm Inc. (Nasdaq: MDRX) announced today that, on September 20, 2023 and as anticipated in its September 18 release, it received a notice from Nasdaq indicating that the Company’s shares would be delisted due to noncompliance with Nasdaq Listing Rule 5250(c)(1), because the Company did not file its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”),... Read More

CHICAGO / Sep 18, 2023 / Business Wire / Veradigm Inc. (Nasdaq: MDRX) announced today that the work effort to conclude on its previously disclosed accounting and internal control errors has taken longer than previously expected, and more time is needed to complete its audit procedures. As such, today the Company will not be filing its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”), or its... Read More

RANCHO SANTA MARGARITA, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Melissa , a leading provider of global data quality, identity verification, and address management solutions, today announced its support of healthcare practice management providers in meeting compliance with Project US@, a federal data initiative to create a unified, industrywide specification for representing patient addresses. “Good data always matters, but... Read More

CHICAGO / Aug 18, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX) announced today that, as expected, it received a notice from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”), Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Q1 Form... Read More

CHICAGO / Jul 20, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX) announced today the signing of two multi-year healthcare provider agreements during the second quarter. One of Veradigm’s largest Veradigm EHR clients, State of Franklin Healthcare Associates (SOFHA), a physician-owned and led primary care and multi-specialty healthcare system in upper East Tennessee and Southwest Virginia, expanded its agreement with... Read More

Company uniquely positioned to drive increased value CHICAGO / Jun 28, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX) reports today strong growth for the preceding six months in its payer segment including: 296 Veradigm Payerpath agreements 6 net-new regional payer, national payer, and aggregator clients signed 16 incremental health plan agreements signed with existing clients, including the new Comprehensive... Read More

CHICAGO / Jun 13, 2023 / Business Wire / Veradigm Inc. (Nasdaq: MDRX) announced today that Nasdaq has accepted the Company’s plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) and granted the Company an exception until September 18, 2023 to file its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”) and Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form... Read More

Annual survey results reveal company receives top ranking in RCM setting for the second consecutive year CHICAGO / Jun 08, 2023 / Business Wire / Veradigm ® (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced that Black Book , a healthcare-centric market research and public opinion research and consulting company, has honored Veradigm Payerpath with the highest ranking in its End-to-End... Read More

CHICAGO / May 19, 2023 / Business Wire / Veradigm Inc . (Nasdaq: MDRX) announced today that, as expected, it received a notice from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”) and Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form... Read More

CHICAGO / Mar 23, 2023 / Business Wire / Veradigm ® (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book , a healthcare-centric market research and public opinion research and consulting company, has ranked Practice Fusion first for Allergy and Immunology and second for Rheumatology within its 2023 Ambulatory EHR by Physician Specialty category . Practice Fusion, a... Read More

CHICAGO / Mar 22, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), announced today an update on the status of its year-end audit procedures for 2022. As the Company disclosed on February 28, 2023, due to an expansion of year-end audit procedures, the Company filed with the SEC a Form 12b-25, extending the due date of its annual report on Form 10-K by 15 days, to allow for completion of those procedures. The reason for... Read More

CHICAGO / Mar 14, 2023 / Business Wire / Veradigm ® (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book , a healthcare-centric market research and public opinion research and consulting company, has ranked Veradigm Practice Management first for its 2023 Practice Management Solutions, 50+ Physician Groups category . Veradigm Practice Management placed in the top five... Read More

CHICAGO / Feb 28, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), announced today that in conjunction with its year-end audit procedures it has detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters, resulting in a mis-statement to reported revenues during those periods. As a result, the Company and its external auditors need to expand procedures and are... Read More

CHICAGO & PHILADELPHIA / Feb 13, 2023 / Business Wire / Veradigm ® , a leading provider of healthcare data and technology solutions (NASDAQ: MDRX), and HealthVerity ® , a leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, today announced a collaboration that will advance real-world research and improve patient care for those with cardiovascular disease and diabetes. The collaboration makes... Read More

CHICAGO / Feb 09, 2023 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), announced today that Veradigm FollowMyHealth (formerly FollowMyHealth), a leading mobile-first patient engagement platform, was recently recognized by KLAS , a prominent healthcare solution evaluator, as Most Improved Software Product in its 2023 Best in KLAS report. With a mobile-first approach, Veradigm FollowMyHealth helps meet patients on their terms... Read More

New delivery format for three integrated electronic health record (EHR) sources to provide delivery flexibility for Veradigm clients CHICAGO / Jan 30, 2023 / Business Wire / Veradigm (NASDAQ: MDRX) announced today that Veradigm Network EHR Data is now available within the OMOP CDM format. Veradigm Network EHR is a complete statistically deidentified dataset containing three integrated EHR sources. This source dataset is now... Read More

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced today that its Board of Directors has approved a new share repurchase program under which Veradigm may purchase up to $250 million of its common stock. The new share repurchase program does not have a termination date and replaces the previous authorization to repurchase $250 million of common stock which was almost fully utilized during... Read More

Veradigm Inc. (NASDAQ: MDRX) reports today strong fourth quarter new business results across all markets including the payer, life science, and provider markets. The Veradigm Payer business added 6 net-new regional and national payer clients in Q4, representing +26% new business growth for the full year, along with expanding business among current clients, worth millions of dollars in total annual contract value. As... Read More

This collaboration fuels the expansion of a leading source of real-world clinical behavioral health data Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced today an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk’s $45 million series B financing round. The round was led by Veradigm, with participation from current... Read More

Veradigm Inc. (Nasdaq:MDRX), formerly Allscripts Healthcare Solutions Inc., announced today that Rick Poulton, Veradigm Chief Executive Officer, will present at the 2023 J.P. Morgan Healthcare conference on Wednesday, January 11, 2023 at 3:45 PST. The live audio webcast and replay can be accessed at the J.P. Morgan public link here . About Veradigm® Veradigm is a healthcare technology company that drives value through its... Read More

Allscripts Healthcare Solutions, Inc. announced today that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand during 2022, and Allscripts will now formally be known as Veradigm. The US healthcare ecosystem – including healthcare providers, biopharma, payers, and the government – is converging around the shared goal of... Read More

Seamless integration enables providers using Veradigm ® Practice Management (formerly Allscripts Practice Management) to accept and post payments within existing workflows NASHVILLE, Tenn. , Nov. 30, 2022 /PRNewswire/ -- Sphere , a leading provider of end-to-end integrated healthcare payments and security software, today announced that its TrustCommerce ® platform is now integrated with the Veradigm ® Practice Management... Read More